Compare COEP & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | HUIZ |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | China |
| Employees | 6 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.2M | 16.8M |
| IPO Year | N/A | 2019 |
| Metric | COEP | HUIZ |
|---|---|---|
| Price | $16.40 | $1.50 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.30 |
| AVG Volume (30 Days) | ★ 92.3K | 10.1K |
| Earning Date | 05-13-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $6.64 |
| P/E Ratio | ★ N/A | $7.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $1.19 |
| 52 Week High | $21.41 | $4.16 |
| Indicator | COEP | HUIZ |
|---|---|---|
| Relative Strength Index (RSI) | 72.18 | 39.85 |
| Support Level | $13.77 | $1.19 |
| Resistance Level | $19.19 | $1.98 |
| Average True Range (ATR) | 1.15 | 0.12 |
| MACD | 0.47 | -0.02 |
| Stochastic Oscillator | 87.62 | 4.65 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.